Jubilant Ingrevia , a leading specialty chemicals company, has reported a robust performance for the second quarter of fiscal year 2026, with significant growth across key financial metrics and an expanding pipeline in its Contract Development and Manufacturing Organization (CDMO) business.

Financial Highlights

The company achieved its highest quarterly revenue in 10 quarters, reaching INR 1,121.00 crore, representing a 7% year-on-year growth. This growth was primarily driven by an impressive 18% volume expansion across its business segments. The financial results also showed:

• EBITDA growth of 8% year-on-year to INR 146.00 crore
• 18% increase in profit after tax to INR 70.00 crore
• Specialty Chemicals segment delivered 12% revenue growth with 26% EBITDA margins

Segment Performance

CDMO and Fine Chemicals Growth

Jubilant Ingrevia has made significant strides in its CDMO and Fine Chemicals business:

• Added over 10 new molecules with INR 1,200.00 crore peak annual revenue potential
• Expanded opportunity funnel to over 100 active opportunities worth INR 3,500.00 crore potential revenue
• Secured a major CDMO contract worth $300.00 million over 5 years, set to begin in early 2026

Sustainability Initiatives

The company has made progress in its sustainability efforts:

• Commissioned renewable power at Bharuch, bringing total renewable share to 28% of power requirements
• Achieved a 16% reduction in energy costs

Future Outlook

Deepak Jain, CEO and Managing Director of Jubilant Ingrevia, expressed optimism about the company's future, stating, "We expect continued growth momentum, fueled by progress in our Specialty Chemicals and Nutrition businesses, along with the expected part recovery in Acetyl portfolio."

The company is also investing in new areas such as semi-conductor chemicals, with plans for a state-of-the-art R&D facility in Greater Noida.

Jubilant Ingrevia's strong performance and expanding pipeline in high-value segments position it well for sustained growth in the coming quarters. The company's focus on CDMO, specialty chemicals, and sustainability initiatives are expected to drive long-term value creation for shareholders.

Jubilant Ingrevia Limited , a leading player in the specialty chemicals sector, has unveiled ambitious plans for growth and expansion in the coming years. The company has announced its intention to introduce 18 new products in FY'26, focusing on high-growth areas including cosmetics and semiconductor chemicals.

Strong Financial Performance

The company reported robust financial results for Q2 FY'26:

Despite challenging market conditions, Jubilant Ingrevia has managed to grow its revenues and maintain profitability. The company's EBITDA grew by 8% year-over-year, while Profit After Tax saw an impressive 18% increase.

Segment-wise Performance

Specialty Chemicals

The Specialty Chemicals segment continued its growth trajectory, reporting margins above 25% during the quarter. This performance was primarily driven by strong sales in Fine Chemicals and CDMO (Contract Development and Manufacturing Organization) offerings.

Nutrition and Health Solutions

The Nutrition and Health Solutions business segment saw volume growth on a year-on-year basis across most segments. However, pricing softness partially offset revenue growth.

Chemical Intermediates

Strategic initiatives in Ethyl Acetate and Acetic Anhydride sales drove notable quarter-on-quarter and year-on-year growth in volumes and revenue, achieving the highest quarterly revenue and volumes in the last six quarters.

Future Outlook and Strategic Initiatives

Looking ahead, Jubilant Ingrevia has set a target of achieving INR 2,000 crore EBITDA by FY'30. The company anticipates continued growth in H2 FY'26, driven by specialty chemicals and nutritional sectors, along with an expected partial recovery in acetyl products.

Key strategic initiatives include:

1. Expansion of the CDMO portfolio with 10+ new molecules added in the last year, expected to contribute INR 1,200 crore+ of peak annual revenues.
2. Groundbreaking of a new multipurpose plant in Gajraula to meet increased CDMO demand.
3. Plans for a state-of-the-art Semiconductor R&D facility in Greater Noida.
4. Continued focus on sustainability initiatives, with renewable power share reaching 28%.

Market Dynamics

The company noted a steady recovery in volumes across the broader chemicals industry, although pricing remains under pressure. The pharmaceutical end-use market continues to show steady volume growth, while the global agrochemical sector has moved beyond the inventory destocking phase.

Jubilant Ingrevia's strategic focus on high-growth areas, coupled with its strong financial performance and expansion plans, positions the company well for future growth in the specialty chemicals sector.

Note: This article is based on the company's latest financial results and statements. Investors are advised to conduct their own research and consult financial advisors before making investment decisions.